Aquestive Therapeutics (AQST) Interest & Investment Income (2018 - 2026)
Aquestive Therapeutics (AQST) posted quarterly Interest & Investment Income of $83000.0 for Q1 2026, down 88.36% year-over-year from $713000.0 in Q1 2025, and down 93.37% quarter-over-quarter from $1.3 million in Q4 2025.
Aquestive Therapeutics (AQST) Interest & Investment Income (2018 - 2026) Analysis & Trends
Aquestive Therapeutics' Interest & Investment Income history runs 9 years deep, the most recent figure standing at $83000.0 for Q1 2026.
- In Q1 2026, Interest & Investment Income fell 88.36% year-over-year to $83000.0; the TTM figure through Mar 2026 stood at $3.7 million (down 2.2% YoY), while the FY2025 annual figure was $4.4 million, up 27.06% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $83000.0, down from $1.3 million in the prior quarter.
- The five-year high for Interest & Investment Income was $14.5 million in Q1 2023, with the low at -$3000.0 in Q1 2022.
- The 5-year median for Interest & Investment Income is $329000.0 (2024), against an average of $1.4 million.
- The sharpest annual moves came in 2023 and 2024: Interest & Investment Income jumped 483866.67% in 2023, then plunged 97.73% in 2024.
- Aquestive Therapeutics' Interest & Investment Income stood at $65000.0 in 2022, then jumped by 153.85% to $165000.0 in 2023, then jumped by 344.85% to $734000.0 in 2024, then surged by 70.57% to $1.3 million in 2025, then tumbled by 93.37% to $83000.0 in 2026.
- Business Quant data shows AQST's Interest & Investment Income at $83000.0 in Q1 2026, $1.3 million in Q4 2025, and $306000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.81 Bn | 42.84 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.29 Bn | 39.63 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.59 Bn | 29.91 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.88 Bn | 5.10 Bn | 154.39 Mn |
| 5 | United Therapeutics | 22.24 Bn | 19.58 Bn | 683.80 Mn | 31.50 Mn |
| 6 | Viatris | 18.79 Bn | 17.91 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.71 Bn | 15.32 Bn | 935.80 Mn | 12.40 Mn |
| 8 | Elanco Animal Health | 12.09 Bn | 11.56 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Aquestive Therapeutics | 556.22 Mn | 556.22 Mn | 9.80 Mn | 882,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 882,000.00 |
| Mar 31, 2026 | 83,000.00 |
| Dec 31, 2025 | 1.25 Mn |
| Sep 30, 2025 | 306,000.00 |
| Jun 30, 2025 | 2.10 Mn |
| Mar 31, 2025 | 713,000.00 |
| Dec 31, 2024 | 734,000.00 |
| Sep 30, 2024 | 979,000.00 |
| Jun 30, 2024 | 1.40 Mn |
| Mar 31, 2024 | 329,000.00 |
| Dec 31, 2023 | 165,000.00 |
| Sep 30, 2023 | 1.51 Mn |
| Jun 30, 2023 | 129,000.00 |
| Mar 31, 2023 | 14.51 Mn |
| Dec 31, 2022 | 65,000.00 |
| Sep 30, 2022 | 5,000.00 |
| Jun 30, 2022 | 32,000.00 |
| Mar 31, 2022 | -3,000.00 |
| Dec 31, 2021 | 135,000.00 |
| Sep 30, 2021 | -33,000.00 |